2021 / 05

Next Paper
DOI: 10.24075/brsmu.2021.047

ORIGINAL RESEARCH

Antitumor effect of radiation therapy on orthotopic PDX models of human esophageal adenocarcinoma

Kiblitskaya AA, Goncharova AS, Anisimov AE, Snezhko AV, Dimitriadi SN, Maslov AA, Gevorkyan YA, Kolesnikov EN
About authors

National Medical Research Center of Oncology, Rostov-on-Don, Russia

Correspondence should be addressed: Alexandra A. Kiblitskaya
14 Liniya, 63, Rostov-on-Don, 344037; moc.liamg@dnaelabik

About paper

Author contribution: Kiblitskaya AA — data processing, manuscript preparation, technical editing, reference list, figures; Goncharova AS, Maslov AA — study concept and design, manuscript preparation; Anisimov AE — study concept and design, manuscript preparation, data acquisition, analysis and interpretation; Snezhko AV — content editing, manuscript preparation; Dimitriadi SN — data analysis and interpretation, technical editing; Gevorkyan YA — content editing; Kolesnikov EN — content and technical editing.

Ethical standards: the study fully complied with the principles of the Declaration of Helsinki; all requirements for animal housing were met; surgical interventions were conducted following the guidelines on the Care and Use of Laboratory Animals. The donors provided informed consent for their biological samples to be used in the study.

Received: 2021-09-16 Accepted: 2021-10-04 Published online: 2021-10-20
|
  1. Gladilina IA, Tryakin AA, Zahidova FO, Malihova OA, Ivanov SM, Kravec OA, i dr. Rak pishhevoda: jepidemiologija, faktory riska i metody diagnostiki. Onkologicheskij zhurnal: luchevaja diagnostika, luchevaja terapija. 2020; 3 (1): 69–76. Russian.
  2. Ho ALK, Smyth EC. A global perspective on esophageal cancer: two diseases in one. The Lancet Gastroenterology & Hepatology. 2020; 5 (6): 521–2. DOI: 10.1016/S2468-1253(20)30047-9.
  3. Enzinger PC, Mayer RJ. Esophageal cancer. New England Journal of Medicine. 2003; 349 (23): 2241–52.
  4. Lin EW, Karakasheva TA, Hicks PD, Bass AJ, Rustgi AK. The tumor microenvironment in esophageal cancer. Oncogene. 2016; 35 (41): 5337–49.
  5. Aksel EM. Statistika zlokachestvennyh novoobrazovanij zheludochno-kishechnogo trakta. Sibirskij onkologicheskij zhurnal. 2017; 16 (3): 5–11. DOI: 10.21294/1814-4861-2017-3-5-11. Russian.
  6. Kit OI. Nejrojendokrinnye, klinicheskie i morfologicheskie aspekty raka zheludka. Novocherkassk: Lik, 2014; 221 s. Russian.
  7. Ishihara R, Oyama T, Abe S, Takahashi H, Ono H, Fujisaki J et al. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. Journal of gastroenterology. 2017; 52 (7): 800–8. DOI: 10.1007/s00535016-1275-0.
  8. Mahoney JL, Condon R. E. Adenocarcinoma of the esophagus. Annals of surgery. 1987; 205 (5): 557.
  9. Urmonov UB, Dobrodeev AYu, Afanasev SG, Avgustinovich AV, Cheremisina OV. Sovremennye aspekty lechenija raka pishhevoda. Sibirskij onkologicheskij zhurnal. 2019; 18 (4): 78–84. DOI: 10.21294/1814-4861-2019-18-4-78-84. Russian.
  10. Hidalgo M, Amant F, Biankin AV, Budinská E, Byrne AT, Caldas C, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014; 4: 998–1013. DOI: 10.1158/2159-8290.
  11. Wilding JL, Bodmer WF. Cancer Cell Lines for Drug Discovery and Development. Cancer Res. 2014; 74 (9): 2377–84. DOI: 10.1158/0008-5472.CAN-13-2971.
  12. Sung-Yup Cho. Patient-derived xenografts as compatible models for precision oncology. Laboratory Animal Research. 2020; 36: 14. DOI: 10.1186/s42826-020-00045-1.
  13. Zhuo J, Su R, Tan W, Lian Z, Lu D, Xu X. The ongoing trends of patient-derived xenograft models in oncology. Cancer Commun (Lond). 2020; 40 (11): 559–63. DOI: 10.1002/cac2.12096.
  14. Fernandes DP, Pimentel MML, Santos FAD, Praxedes ÉA, Brito PD, Lima MA, Lelis ICNG, Macedo MF, Bezerra MB. Hematological and biochemical profile of BALB/c nude and C57BL/6 SCID female mice after ovarian xenograft. An Acad Bras Cienc. 2018; 90 (4): 3941–48. DOI: 10.1590/0001-3765201820180586.
  15. Zhukova GV, Shihlyarova AI, Sagakyanc AB, Protasova TP. O rasshirenii variantov ispol'zovanija myshej BALB/c nude dlja jeksperimental'nogo izuchenija zlokachestvennyh opuholej cheloveka in vivo. Juzhno-Rossijskij onkologicheskij zhurnal. 2020; 1 (2): 28–35. Russian.
  16. Szadvari I, Krizanova O, Babula P. Athymic nude mice as an experimental model for cancer treatment. Physiol Res. 2016; 65 (Suppl 4): S441–53. DOI: 10.33549/physiolres.933526.
  17. Pompili L, Porru M, Caruso C, Biroccio A, Leonetti C. Patientderived xenografts: a relevant preclinical model for drug development. J Exp Clin Cancer Res. 2016; 35 (1): 189. DOI: 10.1186/s13046-016-0462-4.
  18. Choi YY, Lee JE, Kim H, Sim MH, Kim K.-K., Lee G, et al. Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer. Sci Rep. 2016; 6: 22172. DOI: 10.1038/srep22172.
  19. Hoffman RM. Patient-derived orthotopicxenografts: better mimic of metastasis than subcutaneous xenografts. Nat Rev Cancer. 2015; 15: 451–2. DOI: 10.1038/nrc3972.
  20. Tétreault MP. Esophageal cancer: insights from mouse models. Cancer growth and metastasis. 2015; 8: 37–46. DOI: 10.4137/ CGM.S21218.
  21. Bhargava S, Hotz B, Buhr HJ, Hotz HG. An orthotopic nude mouse model for preclinical research of gastric cardia cancer. Int J Colorectal Dis. 2009; 24: 31–9. DOI: 10.1007/s00384-0080584-z.
  22. Rostovcev NM, Kotljarov NA. Sravnitel'nyj analiz jeffektivnosti luchevogo i fotodinamicheskogo lechenija jeksperimental'noj opuholi. Pediatricheskij vestnik Juzhnogo Urala. 2015; 1: 29–32. Russian.
  23. Kolesnikov EN, Kit SO, Lukbanova EA, Goncharova AS, Maksimov AYu, avtory. Federal'noe gosudarstvennoe bjudzhetnoe uchrezhdenie "Rostovskij nauchno-issledovatel'skij onkologicheskij institut" Ministerstva zdravoohranenija Rossijskoj Federacii, patentoobladatel'. Sposob ortotopicheskoj transplantacii kul'tury opuholevyh kletok pishhevoda cheloveka v shejnyj otdel pishhevoda immunodeficitnyh myshej. Patent RF 2713798. G09B 23/28. Zajavka # 2019113616 ot 30.04.19. Russian.
  24. Spiegelberg L, van Hoof SJ, Biemans R, Lieuwes NG, Marcus D, Niemans R, et al. Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity. Radiother Oncol. 2019; 141: 247–55. DOI: 10.1016/j.radonc.2019.06.034.
  25. Shi J-J, Xing H, Wang Y-Х, Zhang X, Zhan Q-М, Geng M-Y, et al. PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment. Cancer Letters. 2019; 459: 145–55. DOI: 10.1016/j.canlet.2019.05.040.
  26. Teicher BA, Andrews PA, editors. Anticancer Drug Development Guide. Preclinical screening, clinical trials, and approval. 2nd ed. Totowa, New Jersey: Humana Press; 2004. DOI: 10.1007/978-159259-739-0.
  27. Treshhalina EM. Immunodeficitnye myshi Balb/c nude i modelirovanie razlichnyh variantov opuholevogo rosta dlja doklinicheskih issledovanij. RBZh. 2017; 16 (3): 6–13. DOI: 10.17650/1726- 9784-2017-16-3-6-13. Russian.